LifeStance Health Group, Inc. LFST
Set alert
13.26 USD -0.14 -1.04%
At close · Nov 2
13.50 +0.24 +1.81%
After hours · Nov 2, 4:00 PM ET
13.18 Day range 13.60
4.77 52-week range 13.76
- YTD
- +88.35%
- 1 year
- +170.61%
- Open
- 13.50
- Prev close
- 13.40
- Mkt cap
- 5.04B
- Vol
- 3.36M
- Avg vol
- 4.40M
- EPS
- 0.13
- P/E
- 102.00
- Div yield
- 0.00%
More statistics
- Low
- 13.18
- High
- 13.60
- Forward P/E
- 30.78
- Beta
- 1.30
- Short ratio
- 2.99
- Inst. own
- 89.69%
- Dividend
- 0.00
- Ex-div date
- Earnings
- Nov 5, 2026
- 50-d avg
- 12.48
- 200-d avg
- 9.34
- 1y target
- 14.45
1M chart
Events in this range
- Oct 5, 2026Rating: Keybanc · Overweight → Overweight
Signals (12)
| Name | Date | Ago |
|---|---|---|
| RSI: Overbought | Oct 29, 2026 | 4 days ago |
| SMA: Bullish | Oct 22, 2026 | 1 week ago |
| MACD: Buy Signal | Oct 22, 2026 | 1 week ago |
| SMA: Bullish | Oct 20, 2026 | 1 week ago |
| SMA: Bearish | Oct 16, 2026 | 2 weeks ago |
| SMA: Bearish | Oct 16, 2026 | 2 weeks ago |
| MACD: Sell Signal | Oct 16, 2026 | 2 weeks ago |
| MACD: Buy Signal | Oct 12, 2026 | 3 weeks ago |
| SMA: Bullish | Oct 9, 2026 | 3 weeks ago |
| SMA: Bearish | Oct 8, 2026 | 3 weeks ago |
| SMA: Bullish | Oct 5, 2026 | 4 weeks ago |
| SMA: Bullish | Oct 5, 2026 | 4 weeks ago |
Analyst view
Consensus: buy
Buy
Price target (mean) 14.45 +9.0% upside
Now 13.26
- Target (low)
- 12.00
- Target (mean)
- 14.45
- Target (high)
- 18.00
Ratings (0m) 11 9 buy · 2 hold · 0 sell
- Strong buy2
- Buy7
- Hold2
- Sell0
- Strong sell0
Recommendation trend
- This month 11
- 1 month ago 11
- 2 months ago 11
Earnings and revenue estimates
Consensus for the coming quarters and fiscal years
| Period | EPS estimate | Low – high | Year ago | EPS growth | Revenue estimate | Revenue growth | Analysts |
|---|---|---|---|---|---|---|---|
| Current quarter | 0.08388 | 0.07 – 0.095 | 0.01444 | +480.9% | 431.58M | +18.6% | 5 |
| Next quarter | 0.08659 | 0.07 – 0.098 | 0.08856 | -2.2% | 438.56M | +14.8% | 5 |
| Current year | 0.35951 | 0.32 – 0.388 | 0.1824 | +97.1% | 1.71B | +20.0% | 5 |
| Next year | 0.43075 | 0.38 – 0.508 | 0.35951 | +19.8% | 1.96B | +14.5% | 5 |
Upgrades and downgrades
The latest rating changes
| Date | Firm | Action | From | To |
|---|---|---|---|---|
| Oct 5, 2026 | Keybanc | Maintained | Overweight | Overweight |
| Sep 10, 2026 | Barclays | Maintained | Overweight | Overweight |
| Sep 9, 2026 | Canaccord Genuity | Maintained | Buy | Buy |
| Aug 19, 2026 | BTIG | Maintained | Buy | Buy |
| Aug 14, 2026 | JP Morgan | Maintained | Neutral | Neutral |
| Aug 7, 2026 | BTIG | Maintained | Buy | Buy |
| Jul 24, 2026 | BTIG | Maintained | Buy | Buy |
| Jul 21, 2026 | Canaccord Genuity | Maintained | Buy | Buy |
| Jul 14, 2026 | Barclays | Maintained | Overweight | Overweight |
| Jul 13, 2026 | Keybanc | Maintained | Overweight | Overweight |
| Jun 5, 2026 | Goldman Sachs | Initiated | Buy | Neutral |
| May 14, 2026 | JP Morgan | Maintained | Neutral | Neutral |
| May 8, 2026 | BTIG | Maintained | Buy | Buy |
| Mar 6, 2026 | Barclays | Maintained | Overweight | Overweight |
| Feb 26, 2026 | Canaccord Genuity | Maintained | Buy | Buy |
| Feb 26, 2026 | UBS | Maintained | Buy | Buy |
| Feb 26, 2026 | Keybanc | Maintained | Overweight | Overweight |
| Feb 2, 2026 | BTIG | Maintained | Buy | Buy |
| Dec 12, 2025 | BTIG | Maintained | Buy | Buy |
| Dec 9, 2025 | Barclays | Initiated | — | Overweight |
| Nov 13, 2025 | BMO Capital | Initiated | — | Outperform |
| Nov 7, 2025 | UBS | Maintained | Buy | Buy |
| Nov 6, 2025 | BTIG | Maintained | Buy | Buy |
| Aug 8, 2025 | UBS | Maintained | Buy | Buy |
| May 27, 2025 | UBS | Upgrade | Neutral | Buy |
| Apr 8, 2025 | Keybanc | Initiated | — | Overweight |
| Apr 3, 2025 | Canaccord Genuity | Initiated | — | Buy |
| Dec 16, 2024 | Goldman Sachs | Upgrade | Neutral | Buy |
| Nov 11, 2024 | Barclays | Maintained | Underweight | Underweight |
| Aug 15, 2024 | UBS | Maintained | Neutral | Neutral |